Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,286 public trials 1,280 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

NCT05057013

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +80 more
Locations: Royal Marsden NHS Foundation Trust London, United Kingdom

The Christie Hospital Manchester, United Kingdom

Freeman Hospital, Newcastle Newcastle, United Kingdom

Churchill Hospital Oxford, United Kingdom

View Trial Details

Active, Not Recruiting

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

NCT04469075

Conditions: Astrocytoma, Disease Attributes, Glioblastoma, +13 more
Locations: Northwestern University Evanston, Illinois, United States

Tufts Medical Center Boston, Massachusetts, United States

Washington University School of Medicine St Louis, Missouri, United States

Hackensack Meridian Health Hackensack, New Jersey, United States

View Trial Details

Active, Not Recruiting

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2

NCT06384417

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +47 more
Locations: Penn State Cancer Institute Hershey, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1

NCT05222932

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

Docrates Cancer Center Helsinki, Finland

View Trial Details

Active, Not Recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions: Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

Highlands Oncology Rogers, Arkansas, United States

UCLA Hematology & Oncology Clinic Los Angeles, California, United States

Sarcoma Oncology Research Center Santa Monica, California, United States

View all 21 locations

View Trial Details

Active, Not Recruiting

NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas

NCT05262556

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +12 more
Locations: University hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Active, Not Recruiting

A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma

NCT06614855

Conditions: Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, +13 more
Locations: The University of Alabama at Birmingham Hospital Birmingham, Alabama, United States

View Trial Details

Active, Not Recruiting

A Study of N9 Chemotherapy in Children With Neuroblastoma

NCT04947501

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Trial of C134 in Patients With Recurrent GBM

NCT03657576

Conditions: Anaplastic Astrocytoma of Brain, Astrocytoma, Brain Diseases, +17 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Active, Not Recruiting

A Model for Genetic Susceptibility: Melanoma

NCT00591500

Conditions: Disease Attributes, Disease Susceptibility, Genetic Predisposition to Disease, +15 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Neoplasms, Nerve Tissue

Neoplasms, Nerve Tissue trial results

Related conditions